Skip to search formSkip to main contentSkip to account menu

Cholecalciferol

Known as: CC, Colecalciferol, d3 vitamin 
A steroid hormone produced in the skin when exposed to ultraviolet light or obtained from dietary sources. The active form of cholecalciferol, 1,25… 
National Institutes of Health

Related topics

Related topics

48 relations
1 ML Calcitriol 0.001 MG/ML InjectionBenzethonium Chloride 2 MG/ML / dimethicone 20 MG/ML Topical LotionCalcifediol AnhydrousCalcitriol

Narrower (7)

24-dehydrocholecalciferolHUM 5007HY-11SMD-429

Broader (2)

CholestenesVitamins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
Primary care Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D 3 ) for prevention of fractures in primary care
Objective To assess whether supplementation with calcium and cholecaliferol (vitamin D 3 ) reduces the risk of fracture in women… 
Highly Cited
2001
Highly Cited
2001
Regulatory T Cells Induced by 1α,25-Dihydroxyvitamin D3 and Mycophenolate Mofetil Treatment Mediate Transplantation Tolerance1
1α,25-Dihydroxyvitamin D3, the active form of vitamin D3, and mycophenolate mofetil, a selective inhibitor of T and B cell… 
Highly Cited
1991
Highly Cited
1991
Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation.
Highly Cited
1989
Highly Cited
1989
Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. Role in cell differentiation.
Review
1988
Review
1988
Nuclear receptors enhance our understanding of transcription regulation.
Review
1988
Review
1988
The vitamin D story: a collaborative effort of basic science and clinical medicine 1
The discovery in 1919‐1924 of vitamin D and its production in skin and foods by UV irradiation led to the elimination of rickets… 
Highly Cited
1984
Highly Cited
1984
Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
Current evidence suggests that administration of 1,25(OH)2D3 to patients with chronic renal insufficiency results in suppression… 
Highly Cited
1979
Highly Cited
1979
Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid.
After mature rats that had been fed on a vitamin D3-deficient diet were injected with tritium-labeled 1,25-dihydroxyvitamin D3… 
Review
1976
Review
1976
Metabolism and mechanism of action of vitamin D.
Progress in the definition of mechanism of action of Vitamin D indicates that the vitamin functions as a prohormone giving rise… 
Highly Cited
1971
Highly Cited
1971
Prevention of early postmenopausal bone loss: controlled 2‐year study in 315 normal females
Abstract. With the aim of preventing postmenopausal bone loss, a placebo‐controlled double‐blind trial of 2 years duration was… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)